Boston Scientific Agrees to Pay $62.5 Million for Xlumena

Boston Scientific has agreed to a $62.5 million deal with Xlumena and its Axios line of biliary devices, putting at least another $12.5 million on the table in potential milestones, according to an article via MassDevice.com.  The move establishes both Boston...

GlaxoSmithKline, U.K. Government Reach MenB Vaccination Agreement

The UK government has reached a deal with drug company GlaxoSmith Kline to be the first worldwide to routinely vaccinate babies against Meningitis B.  According to an article via PharmaTimes.com, “As a result Bexsero, the only licensed MenB vaccine, will now be...